Search

Search Constraints

You searched for: Author/Creator Miranda, Agnese

Search Results

1. Non‐bismuth and bismuth quadruple therapies based on previous clarithromycin exposure are as effective and safe in an area of high clarithromycin resistance: A real‐life study. Issue 4 (20th April 2020)

2. One-year effectiveness and safety of ustekinumab in ulcerative colitis: a multicenter real-world study from Italy. (2nd November 2021)

3. Prevalence of Helicobacter pylori infection in sexual partners of H. pylori‐infected subjects: Role of gastroesophageal reflux. Issue 10 (1st December 2018)

4. An Objective Comparison of Vedolizumab and Ustekinumab Effectiveness in Crohn's Disease Patients' Failure to TNF-Alpha Inhibitors. (13th August 2022)

5. An Objective Comparison of Vedolizumab and Ustekinumab Effectiveness in Crohn's Disease Patients' Failure to TNF-Alpha Inhibitors. (13th August 2022)

6. Telemedicine and Remote Screening for COVID-19 in Inflammatory Bowel Disease Patients: Results From the SoCOVID-19 Survey. Issue 11 (8th October 2020)

7. Empirical levofloxacin-containing versus clarithromycin-containing sequential therapy for Helicobacter pylori eradication: a randomised trial. Issue 11 (14th October 2010)

8. Herbal Products: Benefits, Limits, and Applications in Chronic Liver Disease. (6th September 2012)

9. Telemedicine and Remote Screening for COVID‐19 in Inflammatory Bowel Disease Patients: Results From the SoCOVID‐19 Survey. Issue 11 (November 2020)

10. Activities related to inflammatory bowel disease management during and after the coronavirus disease 2019 lockdown in Italy: How to maintain standards of care. Issue 10 (December 2020)